Pages that link to "Q38347200"

The following pages link to Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding (Q38347200):

Displaying 39 items.

• Identification of new biomarker candidates for glucocorticoid induced insulin resistance using literature mining (Q28708483) (← links)
• Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans (Q34189359) (← links)
• The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism (Q35217521) (← links)
• Diabetes and adrenal disease (Q35535225) (← links)
• Dehydroepiandrosterone: Is There a Role for Replacement? (Q35553087) (← links)
• Direct relationship between elevated free testosterone and insulin resistance in hyperprolactinemic women (Q35939053) (← links)
• Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion (Q36944784) (← links)
• Androgen replacement therapy and cardiovascular function (Q37610408) (← links)
• Impact of Dehydroepiandrosterone Sulfate on Newborn Leukocyte Telomere Length (Q37635378) (← links)
• Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension (Q38336365) (← links)
• Reproductive endocrinologic alterations in female asymptomatic obesity (Q38710165) (← links)
• Association of Dehydroepiandrosterone Sulfate, Body Composition, and Physical Fitness in Independent Community‐Dwelling Older Men and Women (Q39463187) (← links)
• Endogenous sex hormones: impact on lipids, lipoproteins, and insulin (Q40572181) (← links)
• Dehydroepiandrosterone and diseases of aging (Q41190774) (← links)
• Nutrition, hormones, and breast cancer: is insulin the missing link? (Q41227904) (← links)
• Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome (Q42441283) (← links)
• Enhanced Post-Receptor Insulin Effects in Women Following Dehydroepiandrosterone Infusion (Q42448916) (← links)
• Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome (Q42489607) (← links)
• Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors. (Q42490428) (← links)
• Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor (Q42801114) (← links)
• Adiponectin and negative mood in healthy premenopausal and postmenopausal women (Q43059819) (← links)
• Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies (Q43759808) (← links)
• Effects of aging on hypothalamic-pituitary-adrenal system function in non-human primates (Q44014876) (← links)
• Metabolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors (Q46952697) (← links)
• Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. (Q46963670) (← links)
• Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus (Q47850544) (← links)
• Changes in sex hormones during an oral glucose tolerance test in healthy premenopausal women (Q50532919) (← links)
• DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging (Q50883727) (← links)
• Hyperinsulinemia and sex hormones in healthy premenopausal women: Relative contribution of obesity, obesity type, and duration of obesity (Q50912191) (← links)
• Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats (Q51476885) (← links)
• Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. (Q51555751) (← links)
• Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. (Q51588997) (← links)
• Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. (Q54105933) (← links)
• Effects of gonadal androgens and oestrogens on adrenal androgen levels (Q55883477) (← links)
• Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women (Q67898051) (← links)
• Effects of growth hormone administration on dehydroepiandrosterone sulphate, androstenedione, testosterone and Cortisol metabolism during nutritional repletion (Q67902159) (← links)
• Altered adrenal and thyroid function in children with insulin-dependent diabetes mellitus (Q72423357) (← links)
• Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels (Q73267516) (← links)
• Do differences in age specific androgenic steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians? (Q83875562) (← links)